Abiraterone Acetate abione Tablet 250mg

Get a Price/Quote

MOQ : 100 Packs

Abiraterone Acetate abione Tablet 250mg Specification

Origin of Medicine
India

Indication
Prostate cancer

Packaging Type
Box

Dosage Form
Tablet

Brand Name
Abione

Pacakaging (Quantity Per Box)
120 Tablets per box

Life Span
As indicated on packaging (exp. date present on box)

Salt Composition
Abiraterone Acetate

Drug Type
Prescription Medicine

Ingredients
Abiraterone Acetate

Physical Form
Tablet

Function
Antineoplastic - treatment of prostate cancer

Recommended For
Men with metastatic castration-resistant prostate cancer

Dosage
As prescribed by physician

Dosage Guidelines
For oral use only

Quantity
120 Tablets

Storage Instructions
Store in a cool, dry place. Keep away from direct sunlight.

Strength
250mg

Approval
Marketed in multiple countries

Therapeutic Class
Oncology

Color
White (as typical for tablets)

Intended Patients
Male patients only

Marketed By
Abione Pharmaceuticals

Administration Route
Oral

Contraindications
Not for use in women or children

Abiraterone Acetate abione Tablet 250mg Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Abiraterone Acetate abione Tablet 250mg About

Abiraterone Acetate Abione Tablet 250mg stands in the spotlight as an in-demand, pivotal solution for the treatment of metastatic castration-resistant prostate cancer in men. This latest pharmaceutical advancement by Abione Pharmaceuticals embodies classic strength in oncology care, formulated with valorous efficacy for adult male patients. This white, oral medication is marketed in multiple countries, signifying its global trustworthiness and reliability. Strictly for adult men, each prescription-strength tablet contains 250mg of Abiraterone Acetate, delivered in secure packaging of 120 tablets per box, ensuring proper storage and longevity as indicated.

Key Uses and Method of Application

Abiraterone Acetate Abione Tablet 250mg is purposefully used for men with metastatic castration-resistant prostate cancer. Administered strictly by oral route, its application method is simple: swallow the tablet whole with water, as prescribed by your physician. The primary application place remains outpatient oncology clinics or at home, under careful medical supervision. Its targeted, controlled usage underscores its pivotal role in advanced cancer therapy.

FOB Port, Certifications, and Supply Capability

Abiraterone Acetate Abione Tablet 250mg offers prompt handover and secure drop-off at designated FOB ports in India, ensuring efficient export operations. Abione Pharmaceuticals guarantees that each batch meets stringent certifications, evidencing safety and quality. With robust manufacturing, the supply ability remains strong to meet in-demand healthcare needs globally, allowing consistent offer and delivery for medical facilities and authorized traders worldwide.

FAQ's of Abiraterone Acetate abione Tablet 250mg:

Q: How should Abiraterone Acetate Abione Tablet 250mg be taken?

A: The tablet should be taken orally with water, exactly as prescribed by your physician. Follow the recommended dosage and schedule for best therapeutic results.

Q: What is the intended use of Abiraterone Acetate Abione Tablet 250mg?

A: It is indicated for the treatment of men with metastatic castration-resistant prostate cancer. It works as an antineoplastic agent to help manage advanced prostate cancer.

Q: When should this medication not be used?

A: This medication is contraindicated in women and children. It should be used only by adult male patients as per physician's guidance.

Q: Where is Abiraterone Acetate Abione Tablet 250mg available?

A: The tablet is marketed in multiple countries, with manufacture, supply, and trading operations primarily based in India by Abione Pharmaceuticals.

Q: What benefits does Abiraterone Acetate Abione Tablet 250mg offer?

A: It provides a clinically proven approach to managing metastatic prostate cancer, allowing for improved outcomes and quality of life when other treatments are no longer effective.